Early Alzheimer's Disease Clinical Trials

22 clinical trials for Early Alzheimer's Disease across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) — RECRUITING · PHASE2
• A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease — RECRUITING · PHASE2
• Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. — RECRUITING · PHASE2
• A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Intravenous Sabirnetug in Early Alzheimer’s Disease — RECRUITING · PHASE2
• Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease — RECRUITING · NA
• An Exploratory Phase 2 Multicenter, Double-blind, Randomized, Placebo controlled, Parallel Group Study to Investigate the Safety, Tolerability, and Efficacy of TML-6 in Early Alzheimer’s Disease — NOT_YET_RECRUITING · PHASE2
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — ACTIVE_NOT_RECRUITING · PHASE2
• A Randomized, Double-blind, Placebo-controlled, Global Proof-of-concept Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1) — TERMINATED · PHASE2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants with Early Alzheimer’s Disease — TERMINATED · PHASE1
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — COMPLETED · PHASE3
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — COMPLETED · PHASE3
• Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — TERMINATED · PHASE3
• High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease — COMPLETED · NA
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — ACTIVE_NOT_RECRUITING · PHASE3
• A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's Disease — NOT_YET_RECRUITING
• Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease — COMPLETED · PHASE2
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — COMPLETED · PHASE3
• Characterization of Immune Response in Participants from a Posdinemab Study — OTHER · PHASE1
• A Phase 2b, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients with Early Alzheimer’s Disease - ADVANCE — COMPLETED · PHASE2
• Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease — COMPLETED · PHASE2
• Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease — OTHER · PHASE2
• A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects — COMPLETED · PHASE1

Refine this search